Schizophrenia Research
Volume 92, Issue 1 , Pages 68-73 , May 2007

Remission criteria for schizophrenia: Evaluation in a large naturalistic cohort

  • Marc De Hert

      Affiliations

    • University Psychiatric Centre Catholic University Louvain, Leuvensesteenweg 517, 3070 Kortenberg, Belgium
    • Corresponding Author InformationCorresponding author. Tel.: +32 2 7580546; fax: +32 2 7595380.
    • ,
  • Ruud van Winkel

      Affiliations

    • University Psychiatric Centre Catholic University Louvain, Leuvensesteenweg 517, 3070 Kortenberg, Belgium
    • Department of Psychiatry and Neuropsychology, EURON, South Limburg Mental Health Research and Teaching Network, Maastricht University; PO box 616, 6200 MD Maastricht, The Netherlands
    • ,
  • Martien Wampers

      Affiliations

    • University Psychiatric Centre Catholic University Louvain, Leuvensesteenweg 517, 3070 Kortenberg, Belgium
    • ,
  • John Kane

      Affiliations

    • The Zucker Hillside Hospital, New York, USA
    • ,
  • Jim van Os

      Affiliations

    • Department of Psychiatry and Neuropsychology, EURON, South Limburg Mental Health Research and Teaching Network, Maastricht University; PO box 616, 6200 MD Maastricht, The Netherlands
    • ,
  • Joseph Peuskens

      Affiliations

    • University Psychiatric Centre Catholic University Louvain, Leuvensesteenweg 517, 3070 Kortenberg, Belgium

Received 14 November 2006 ,Revised 8 January 2007 ,Accepted 9 January 2007.

References 

  1. Andreasen NC, Carpenter WT, Kane JM, Lasser RA, Marder SR, Weinberger DR. Remission in schizophrenia: proposed criteria and rationale for consensus. Am. J. Psychiatry. 2005;162(3):441–449
  2. Carr VJ. Recovery from schizophrenia: a review of patterns of psychosis. Schizophr. Bull. 1983;9:98–119
  3. De Hert M, Wampers M, Thys E, Wieselgren I, Lindström E, Peuskens J. Validation of PECC, interscale validity and inter-rater reliability. Int. J. Psychiatry Clin. Pract. 2002;6:135–140
  4. De Hert M, Wampers M, Peuskens J. Pharmacological treatment of hospitalised schizophrenic patients in Belgium. Int. J. Psychiatry Clin. Pract. 2006;10(4):285–290
  5. De Hert, M., van Winkel, R., Wampers, M., Peuskens, J., in press. Anticholinergic use is hospitalised schizophrenic patients in Belgium. Psychiatry Res.
  6. Guy W. E.C.D.E.U. Assessment Manual for Psychopharmacology. Rockville MD: Department of Health, Education and Welfare; 1976;
  7. Helldin L, Kane J, Karilampi U, Norlander T, Archer T. Remission and cognitive ability in a cohort of patients with schizophrenia. J. Psychiatr. Res. 2006;40(8):738–745(Electronic publication 2006 Sep 11)
  8. Jones SH, Thornicroft G, Coffey M, Dunn G. A brief mental health outcome scale-reliability and validity of the Global Assessment of Functioning GAF. Br. J. Psychiatry. 1995;166:654–659
  9. Kane JM, Leucht S, Carpenter D, Docherty JP. Expert consensus guideline series. Optimizing pharmacologic treatment of psychotic disorders. Introduction: methods, commentary, and summary. J. Clin. Psychiatry. 2003;64(Suppl 12):5–19
  10. Lasser RA, Bossie CA, Gharabawi GM, Kane JM. Remission in schizophrenia: results from a 1-year study of long-acting risperidone injection. Schizophr. Res. 2005;77:215–227
  11. Malla A, Norman R, Schmitz N, Manchanda R, Bechard-Evans L, Takhar J, et al. Predictors of rate and time to remission in first-episode psychosis: a two-year outcome study. Psychol. Med. 2006;36(5):649–658(Electronic publication 2006 Mar 6)
  12. Peuskens, J., Kane, J., Nasrallah, H., submitted for publication. Symptomatic remission in schizophrenia: reflections on a new concept and a visual representation of its course.
  13. van der Gaag M, Cuijpers A, Hoffman T, Remijsen M, Hijman R, de Haan L, et al. The five-factor model of the Positive and Negative Syndrome Scale I: confirmatory factor analysis fails to confirm 25 published five-factor solutions. Schizophr. Res. 2006;85:273–279
  14. van der Gaag M, Hoffman T, Remijsen M, Hijman R, de Haan L, van Mijel B, et al. The five-factor model of the Positive and Negative Syndrome Scale II: a ten-fold cross-validation of a revised model. Schizophr. Res. 2006;85:280–287
  15. van Os J, Burns T, Cavallaro R, Leucht S, Peuskens J, Helldin L, et al. Standardized remission criteria in schizophrenia. Acta Psychiatr. Scand. 2006;113:91–95
  16. van Os J, Drukker M, à Campo J, Meijer J, Bak M, Delespaul P. Validation of remission criteria for schizophrenia. Am. J. Psychiatry. 2006;163(11):2000–2002
  17. Wunderink L, Nienhuis F, Sytema S, Wiersma D. Predictive validity of proposed remission criteria in first-episode schizophrenic patients responding to antipsychotics. Schizophr Bull. 2006;2006 Aug 7; [Epub ahead of print] PMID: 16894026 [PubMed - as supplied by publisher]

PII: S0920-9964(07)00062-X

doi: 10.1016/j.schres.2007.01.010

Schizophrenia Research
Volume 92, Issue 1 , Pages 68-73 , May 2007

Article Tools